Aug 11, 2021 / 08:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Q2 2021 Xenon Pharmaceuticals Inc. Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Ms. Jodi Regts. Thank you. Please go ahead.
Jodi Regts - Xenon Pharmaceuticals Inc. - VP of Corporate Affairs & IR
Thank you. Good afternoon. Thanks for joining us on our call and webcast to discuss our second quarter 2021 financial and operating results. Joining me on today's call are Ian Mortimer, Xenon's President, and Chief Executive Officer; Simon Pimstone, Executive Chair of Xenon's Board; Sherry Aulin, Xenon's Chief Financial Officer; and Chris Von Seggern, Xenon's Chief Commercial Officer.
Please be advised that during this call, we will make a number of statements that are forward-looking, including statements regarding the anticipated impact and timing of the COVID-19 pandemic on our business, research and clinical development plans and timelines and results of operations, the timing of and
Q2 2021 Xenon Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot